Novartis is a top pharmaceutical company based in Basel, Switzerland.The company was founded in 1996, through the merger of Ciby-Geigy (Ciba formed in 1856 and Geigy in 1758) and Sandoz (formed 1886).

Novartis is engaged in the discovery, development, manufacture and sale of innovative products to prevent and cure diseases, to ease suffering and enhance the quality of life.

Report: Partnering Deals and Alliances with Novartis

Novartis is a top pharmaceutical company based in Basel, Switzerland.

The company was founded in 1996, through the merger of Ciby-Geigy (Ciba formed in 1856 and Geigy in 1758) and Sandoz (formed 1886).

Novartis is engaged in the discovery, development, manufacture and sale of innovative products to prevent and cure diseases, to ease suffering and enhance the quality of life.

The company has six core businesses:

• Pharmaceuticals – Novartis is recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side-effects
• Vaccines and diagnostics – Novartis is a leader in providing products to fight vaccine-preventable viral and bacterial diseases and to help prevent transfusion-related transmission of HIV and other viruses
• Sandoz (generics) –  Sandoz is a global leader in the rapidly growing generics industry, delivering affordable, high-quality medicines to patients worldwide
• Animal health – Animal Health focuses on the well-being of companion animals and on the health and productivity of farm animals
• Alcon (eye care) – Alcon is the global leader in eye care, with surgical, ophthalmology and consumer products. The CIBA Vision business focuses on contact lenses and lens-care products
• Over the counter – Over-the-Counter (OTC) is a world leader in the research, development, production and marketing of self-medication products that do not require prescriptions

Novartis has an active licensing partnering group that combining expertise is key to innovation and success. Novartis often achieve success through close collaboration with partners who share a common vision and complementary strengths. A key Novartis priority is to build winning collaborations in the research of new medicines and vaccines more

Novartis announced over 265 partnering / licensing deals since 2005, with 23 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology, infectives, central nervous system, genitourinary and respiratory diseases more

Novartis has also announced 18 M&A deals since 2005, with the lead deals being the acquisition of Alcon and Fougera more

Report: Partnering Deals and Alliances with Novartis

Examples of recent partnering and licensing deals announced by Novartis can be viewed in Current Partnering's Novartis partnering activity review article.

Examples of recent M&A deals announced by Novartis can be viewed in Current Partnering's Novartis M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Novartis

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Novartis

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Novartis     

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Novartis company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk